Navigation Links
Novartis Consumer Health Inc. Issues Voluntary Nationwide Recall of Certain Over-the-Counter Products Due to Potential Presence of Foreign Tablets or Chipped or Broken Tablets or Gelcaps
Date:1/8/2012

p>

 100008461

Excedrin® Migraine Caplets 125CT Bonus Pack New Carton

300672039866

10300672039863

0067203986

 100007215

Excedrin® Migraine Caplets 125CT Bonus Pack

300672039835

10300672039832

0067203983

 100008090

Excedrin® Migraine Caplets 200CT New Label

300672039927

10300672039924

0067203992

 100009016

Excedrin® Migraine Caplets 24+6CT Bonus Pack

300672039309

10300672039306

0067203930

 100003182

Excedrin® Migraine Caplets 24CT

300672039248

10300672039245

0067203924

 100008084

Excedrin® Migraine Caplets 24CT New Label

300672039248

10300672039245

0067203924

 100008809

Excedrin® Migraine Caplets 250+50CT Bonus Pack

300672039576

10300672039573

0067203955

 100004174

Excedrin® Migraine Caplets 250CT No Carton

300672039071

10300672039078

0067203907

 100008093

Excedrin® Migraine Caplets 250CT No Carton New Label

300672039071

10300672039078

0067203907

 100004870

Excedrin® Migraine Caplets 250CT Special Inners

300672039774

10300672039771

0067203977

 100008091

Excedrin® Migraine Caplets 250CT New Label

300672039774

10300672039771

0067203977

 100003121

Excedrin® Migraine Caplets 300CT

300672039330

10300672039337

0067203933

 100007469

Excedrin® Migraine Caplets 300CT New Carton

300672039330

10300672039313

0067203933

 100008092

Excedrin® Migraine Caplet
'/>"/>

SOURCE Novartis Consumer Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec®
2. New Data Confirms Novartis Drug Afinitor® Significantly Extends Time Women With Advanced Breast Cancer Live Without Tumor Growth
3. Novartis Study Shows QTI571 Significantly Improved Walking Distance in Patients with Life-Threatening Pulmonary Arterial Hypertension
4. Novartis Drug Afinitor® Effective in Patients With Non-Cancerous Kidney Tumors Associated With TSC in Phase III Trial
5. Novartis Study Showed ACZ885 Provided Substantial Symptom Relief in 84% of Patients With the Most Serious Form of Childhood Arthritis
6. Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
7. Novartis Drug Gleevec® Shows Significant Overall Survival Benefit for Patients With GIST After Three Years of Adjuvant Treatment vs. One Year
8. Novartis highlights extensive data on numerous compounds at ASCO in multiple cancers, including Phase III studies in GIST and myelofibrosis
9. Novartis Data Shows ACZ885 for Severe Gouty Arthritis Provided Better Pain Relief and Reduced Risk of New Attacks by Up to 68% vs. Steroid
10. FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors
11. Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... SAN DIEGO , July 2, 2015 ResMed ... report its fourth quarter and fiscal year ended June 30, ... York Stock Exchange market close. A press release with ResMed,s ... and the company will host a webcast to discuss operating ... scheduled to begin at 1:30 p.m. US Pacific Time and ...
(Date:7/2/2015)... 2, 2015 Roche,s Bloodhound technology is ... segment in hematology testing, according to Kalorama Information.  ... unveiling of its Bloodhound digital cell imaging technology ... 511 hematology analyzer – is notable as ... by current leader CellaVision, but also compete more ...
(Date:7/2/2015)... FRANCISCO , July 2, 2015  The Green ... ), the world,s first HIPAA compliant mobile app that ... of farm-to-table fresh medical marijuana, announced today that their ... Unlike Eaze, Meadow and more than half a ... the last year, Loud Cannabis is unique in that ...
Breaking Medicine Technology:ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 2Kalorama: With Bloodhound, Roche Closes in on High-Growth Hematology Segment 3New Cannabis Delivery App Gets Product to Patient in Under 7 Minutes 2
... the makers of an eco-friendly breastpump that ... their own personal accessory set, today announces its new ... program makes it easy for individual breastfeeding mothers ... including WIC, to return their Hygeia pump to Hygeia ...
... A VANIR Pharmaceuticals, Inc. ... A. Katkin, AVANIR,s President and CEO, together with other ... will ring the NASDAQ Stock Market Opening Bell on ... the recent U.S. Food and Drug Administration (FDA) approval ...
Cached Medicine Technology:Hygeia Introduces Environmentally Preferable Product Breastpump Program to Enable Mothers to Recycle and Refurbish Used Breastpumps 2AVANIR Pharmaceuticals Announces NASDAQ Opening Bell Ceremony 2AVANIR Pharmaceuticals Announces NASDAQ Opening Bell Ceremony 3AVANIR Pharmaceuticals Announces NASDAQ Opening Bell Ceremony 4AVANIR Pharmaceuticals Announces NASDAQ Opening Bell Ceremony 5
(Date:7/4/2015)... Jacksonville, Florida (PRWEB) , ... July 04, 2015 ... ... Society of Plastic Surgeons published the results of an annual member survey ... throughout the United States. More recently, the group broke that raw data down ...
(Date:7/3/2015)... (PRWEB) , ... July 04, 2015 , ... The Harvest Hope Food Bank ... July. Four local AlignLife offices in the area of Greenville SC are making ... to be made by patients only. They are asking for donations from the public as ...
(Date:7/3/2015)... , ... July 03, 2015 , ... Scientists at several ... to mesothelioma with even minimal asbestos exposure. Click here to read the complete ... University of Hawaii Cancer Center, Cedars Sinai Medical Center, and New York University exposed ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Erie County Bar ... at 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy Esq. of William Mattar ... points of investigating these types of cases. , Each year, New York State ...
(Date:7/3/2015)... ... July 03, 2015 , ... First Choice Emergency Room , the largest ... MD as the new Medical Director of its Frisco facility. , “We are pleased ... facility,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
Breaking Medicine News(10 mins):Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 2Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 3Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3
... 2009 AMERIGROUP Corporation (NYSE: ... earnings for the fourth quarter ended December 31, 2008, ... At 8:30 a.m. Eastern Time on the same ... webcast to discuss earnings and other information.To listen to ...
... therapy, researchers say , , WEDNESDAY, Jan. 21 (HealthDay News) ... those don,t interfere with any medical treatments they might be ... was a 55-year-old man being treated for thyroid cancer who ... of his treatment, but his levels of iodine continued to ...
... pollution correlate with increases in life expectancy , , WEDNESDAY, ... there is a direct relationship between the level of ... expectancy in cities across the United States. , Reducing ... damaging kind -- by 10 micrograms per cubic meter ...
... be the new central clearing house for an ambitious ... range of biomedical data to make it more accessible ... Research Resources, a component institute of the National Institutes ... to support the Biomedical Informatics Research Network Coordinating Center ...
... can offer hope of better hearing for people who ... by the non-profit educational organization Better Hearing Institute (BHI). ... United States and Canada found that six out of ... using hearing aids and two of ten reported major ...
... loved ones in research studies , , WEDNESDAY, Jan. ... family members enroll them in disease research studies should ... new study says. , The findings, based ... helpful in studying people with Alzheimer,s disease, which often ...
Cached Medicine News:Health News:AMERIGROUP Corporation to Discuss Fourth Quarter Earnings on February 19 2Health News:Supplement Hampers Thyroid Cancer Treatment 2Health News:Cleaner Air Equals Longer Life 2Health News:Cleaner Air Equals Longer Life 3Health News:USC awarded $22.2M NIH national biomedical informatics infrastructure coordinating center contract 2Health News:Hearing Aids Offer Hope for Those Who Suffer from Persistent 'Ringing in the Ears,' Better Hearing Institute Survey Finds 2Health News:Hearing Aids Offer Hope for Those Who Suffer from Persistent 'Ringing in the Ears,' Better Hearing Institute Survey Finds 3Health News:Hearing Aids Offer Hope for Those Who Suffer from Persistent 'Ringing in the Ears,' Better Hearing Institute Survey Finds 4Health News:Decide for Me When I Can't, Most People Say 2
High sensitive, specific one step immunochromatographic assay for human infectious disease...
Detection of Malarial antigen in Human whole blood....
The KAT-Quick Malaria test was designed for the diagnosis of Malaria, in laboratories, the home and for medical kits when travelling into malaria regions....
The Malaria Combo Test is a rapid test for the qualitative detection of Plasmodium falciparum and / or Plasmodium vivax , Plasmodium ovale and Plasmodium malariae antigen in whole blood. This ...
Medicine Products: